Shape Your Career

Judy Keen

With over 20 years of experience, Judy Keen is a leader in driving change and innovation in medicine. Through her work in academia, government, non-profit medical professional societies, and in the pharmaceutical industry, Judy understands the business of medicine from many angles. She has developed resources for scientists, created external partnerships to help fill gaps in scientific knowledge, and supported advancing professional careers of emerging scientific researchers. Her work has included the development of a national biorepository and genomic database program, establishment and management of numerous research grant programs, development of novel partnerships with philanthropies, medical associations, and industry to further biomedical research. Most recently, Judy has worked to integrate digital tools into clinical care and clinical trials by partnering with technology companies, venture firms, associations and pharmaceutical companies. Through her work and volunteer activities, Judy has extensive experience in serving on and managing volunteer advisory and leadership boards and committees. She currently serves at the Chair of the Johns Hopkins Press Advisory Board, as Vice President of the Hopkins Alumni Council, and is as a member of the Board of Trustees at the Johns Hopkins University. 

Afoke Kokogho

MD, MPH, MMSc

Experienced physician (since 2012) and published scientist. Passionate about preventive and therapeutic investigational new drug development, vaccine trials, and epidemiological studies within the infectious disease landscape.

Pipeline projects completed or ongoing: Ebola vaccine, Lassa fever vaccine, COVID-19 vaccine, HIV vaccine, Cholera vaccine, and most recently Cytomegalovirus (CMV) vaccine candidate.

Highly skilled in leading cross-functional teams in fast-paced environments. I am dedicated to delivering results in a timely manner. As a team player, I believe in the power of innovative ideas and strong collaborations to stay ahead of the science.

Amir Khan

"I graduated from medical school in 2019 and graduated with an MPH from Johns Hopkins Bloomberg School of Public Health in 2022. While at Hopkins, I took advanced-level Epidemiology and Biostatistics Courses sequentially throughout the program. These skills were sufficient enough to equip me with an understanding of Data, from collection to exploration to analysis. I specialize in analyzing a wide variety of data, and designing clinical research studies, and clinical trials.  

Starting in 2022, soon after graduation, I started working as a Research Fellow at the University of Maryland Medical Center in the Department of Urology. I proficiently utilize national databases such as SEER Research, SEER-Medicare Linked Data, NCDB, NSQIP, VSQIP, UNOS, NHANES, AQUA, NTDB, and institutional databases for finding new diagnostic and treatment plans for urologic oncology such as Prostate cancer, Bladder cancer, Kidney cancer, and Testicular cancer. I believe that in a few years, I will have a handful of useful products in my field and undoubtedly, Johns Hopkins provided the foundation for this." 

Larissa Assam

Dr. Assam is a Family Medicine physician, entrepreneur, author, and philanthropist. She is the Founder of Rophe Beauty, the only physician founded and formulated all-natural international beauty and skincare enterprise.



She provides Presidential-level aesthetic and holistic health services to religious and political dignitaries through her private practice, RopheMD.



She was born and raised in Cameroon where in she was called into medicine at age 7 after her father was involved in a ghastly car accident and the passion for entrepreneurship was fostered. She is an alumnus of SUNY Oswego, SUNY Upstate Medical University & Johns Hopkins Bloomberg School of Public Health. She completed Family Medicine Residency at the Georgetown-Washington Hospital Center Family Medicine program where she received several awards for outstanding patient care and teaching Georgetown medical students. Dr. Assam worked as Strategy Consultant at McKinsey & Company helping Fortune 500 companies solve complex business problems.



She is passionate about beauty, entrepreneurship, helping people prevent disease, reverse disease, and raising the next generation of physicians.

Rebecca Ehrenkranz

Rebecca is currently a postdoctoral research fellow at the Johns Hopkins Center for Psychedelic and Consciousness Research. She completed her PhD in epidemiology with a focus on population neuroscience at the University of Pittsburgh School of Public Health. Her dissertation research analyzed the neural correlates of subjective wellbeing in older adults. She previously completed her Master of Public Health at the Johns Hopkins Bloomberg School of Public Health, and her past research experience includes a fellowship at the National Cancer Institute and a data analyst position at Dana-Farber Cancer Institute.  

Oluwadamilola(Dami) Onasanya

Oluwadamilola ‘Dami’ Onasanya serves as a Senior Researcher within the Safety and Epidemiology team at Carelon Research (formerly known as HealthCore, Inc.). In this role, Dami serves as the Principal Investigator in postmarketing requirement (PMR) safety and effectiveness studies of newly approved drugs, mainly in the oncology and chronic inflammatory therapeutic areas. Dami also leads the development and validation of claims-based algorithms, novel causal inference research methods, including machine learning for causal inference methods in large, real-world healthcare data assets. He is the Chair of the International Society of Pharmacoepidemiology’s funded manuscript writing team leading the charge to develop frameworks for estimating oncology lines of therapy in real-world data. Prior to Carelon Research, Dami was at the Johns Hopkins Bloomberg Center for Drug Safety and Effectiveness where he worked as a Senior Research Data Analyst and has worked as a Medical Officer in the Oncology and Palliative Care Unit of the Federal Medical Center, Abeokuta, Nigeria. He has over 15 years’ experience in both the clinical management of cancer and chronic inflammatory conditions, and technical pharmacoepidemiologic methods and RWD analytics expertise. He has an MD degree from Olabisi Onabanjo University Nigeria, an MPH from the Johns Hopkins Bloomberg School of Public Health, and is a 5th year PhD candidate in Pharmaceutical Health Services Research (Pharmacoepidemiology track) at the University of Maryland, Baltimore.